News
Australian comedian Magda Szubanski is set to undergo the Nordic Protocol, a rigorous chemotherapy regimen, after being ...
QuidelOrtho Corporation (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs, and transfusion medicine, ...
NORTHAMPTON, MA / ACCESS Newswire / June 3, 2025 / By Guy Diedrich, Ph.DIn every corner of the globe, digital technology is becoming the bridge to opportunity, empowerment, and transformation. Cisco's ...
4d
News-Medical.Net on MSNMass General Brigham researchers share cancer research discoveries at ASCO 2025Researchers from Mass General Brigham will present research discoveries and outcomes from clinical trials in cancer at the ...
3d
Onlymyhealth on MSNChildhood Cancer Treatment: Expert Explains Advances In Treating DIPG, A Deadly Brain CancerDiffuse Intrinsic Pontine Glioma DIPG is a rare and aggressive form of childhood brain cancer Scroll down to learn about this ...
In the DESTINY-Breast09 study, Enhertu (fam-trastuzumab deruxtecan-nxki) plus pertuzumab reduced the risk of disease ...
Metastatic breast cancer market is projected to grow significantly through 2035, driven by rising cases, treatment advances, and expanding R&D investments.
The drug has been reported previously to cause neuropathy and hypersensitivity reactions in breast cancer patients.
Magda Szubanski will undergo one of the 'best' - yet most intense - treatments after receiving a soul-crushing stage four ...
Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer Enrollment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results